161 related articles for article (PubMed ID: 4006047)
1. Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.
Ramu A; Fridkin M; Steinherz R
Cancer Chemother Pharmacol; 1985; 15(1):31-4. PubMed ID: 4006047
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
3. Dihydrofolate reductase activity in adriamycin and methotrexate sensitive and resistant P388 leukemia cells.
Mandelbaum-Shavit F; Ramu A
Cell Biol Int Rep; 1987 May; 11(5):389-96. PubMed ID: 3607890
[TBL] [Abstract][Full Text] [Related]
4. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
5. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.
Chitnis MP; Kamath NS
Oncology; 1987; 44(1):47-50. PubMed ID: 3561929
[TBL] [Abstract][Full Text] [Related]
6. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
Ramu A; Fuks Z; Gatt S; Glaubiger D
Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
Ramu A; Shan TC; Glaubiger D
Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
[TBL] [Abstract][Full Text] [Related]
8. Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
Capranico G; Dasdia T; Zunino F
Int J Cancer; 1986 Feb; 37(2):227-31. PubMed ID: 3943921
[TBL] [Abstract][Full Text] [Related]
9. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
Kamath NS; Chitnis MP
Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
[TBL] [Abstract][Full Text] [Related]
10. Differential agglutination of P388 adriamycin-sensitive and P388 adriamycin-resistant leukemia cells.
Basrur VS; Chitnis MP; Menon RS
Oncology; 1983; 40(3):202-4. PubMed ID: 6843944
[TBL] [Abstract][Full Text] [Related]
11. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D; Schmidt H
Biochem Pharmacol; 1986 Feb; 35(4):673-8. PubMed ID: 3947398
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to anthracyclines in P388/dx leukaemia cells.
Bossa R; Dasdia T; Galatulas I; Zunino F
Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
[TBL] [Abstract][Full Text] [Related]
14. Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Turinic R; Valenzuela R
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):799-806. PubMed ID: 6540180
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
Hait WN; Pierson NR
Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M
Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108
[TBL] [Abstract][Full Text] [Related]
17. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
Ramu A; Cohen L; Glaubiger D
Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
[TBL] [Abstract][Full Text] [Related]
18. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
[TBL] [Abstract][Full Text] [Related]
19. Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine.
Inaba M; Fujikura R; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1981 Aug; 30(15):2191-4. PubMed ID: 7295334
[No Abstract] [Full Text] [Related]
20. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
Satyamoorthy K; Deshpande SS; Chitnis MP
Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]